Difference between revisions of "Reduce Access to Precursor Ingredients"
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | + | <div class="wiki" id="content_view" style="display: block"> | |
− | Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]]<span style="font-size: 13px;">or </span>[[ZOOM_MAP_-_Minimize_Diversion_of_Prescription_Drugs|Zoom Map - (Minimize Diversion of Prescription Drugs)]] | + | Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]]<span style="font-size: 13px;">or </span>[[ZOOM_MAP_-_Minimize_Diversion_of_Prescription_Drugs|Zoom Map - (Minimize Diversion of Prescription Drugs)]]__TOC__ |
− | + | ||
− | + | | |
− | + | ||
= Background = | = Background = | ||
Line 11: | Line 11: | ||
== NPLEx == | == NPLEx == | ||
− | <div class="_">National Precursor Log Exchange (NPLEx) adopted by 33 states across the country, helps law enforcement in the fight against meth lab production by blocking unlawful purchases of medicine containing PSE at the pharmacy counter, in real-time, and across state lines. Across the country, over 44,000 retailers use the NPLEx system and some states have gone further and use NPLEx to ban the sale of any PSE products to those previously convicted of a meth crime.<sup class="reference"> | + | <div class="_">National Precursor Log Exchange (NPLEx) adopted by 33 states across the country, helps law enforcement in the fight against meth lab production by blocking unlawful purchases of medicine containing PSE at the pharmacy counter, in real-time, and across state lines. Across the country, over 44,000 retailers use the NPLEx system and some states have gone further and use NPLEx to ban the sale of any PSE products to those previously convicted of a meth crime.<sup class="reference"><ref>https://www.naddi.org/naddi-releases-2016-statistics-for-nplex-system/</ref></sup> A similar system could be used for opioids.<br/> </div> <div class="_"> </div> |
= Tools & Resources = | = Tools & Resources = | ||
Line 22: | Line 22: | ||
= Resources to Investigate = | = Resources to Investigate = | ||
− | [[ | + | [[RTI_-_Reduce_Access_to_Precursor_Ingredients|More RTI on Reduce Access to Precursor Ingredients]]<br/> <br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">PAGE MANAGER</span>:''' </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[insert name here]</span><br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">SUBJECT MATTER EXPERT</span>''': </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[fill out table below]</span> |
{| class="wiki_table" | {| class="wiki_table" | ||
Line 39: | Line 39: | ||
---- | ---- | ||
− | + | | |
− | + | </div> | |
+ | [[Category:SAFE-Law Enforcement and Criminal Justice]] [[Category:SAFE-Prescriptions and Medical Response]] |
Latest revision as of 20:24, 28 June 2021
Return to Opioid Top-Level Strategy Mapor Zoom Map - (Minimize Diversion of Prescription Drugs)
Contents
Background
Programs
NPLEx
National Precursor Log Exchange (NPLEx) adopted by 33 states across the country, helps law enforcement in the fight against meth lab production by blocking unlawful purchases of medicine containing PSE at the pharmacy counter, in real-time, and across state lines. Across the country, over 44,000 retailers use the NPLEx system and some states have gone further and use NPLEx to ban the sale of any PSE products to those previously convicted of a meth crime.[1] A similar system could be used for opioids.
Tools & Resources
TR - Reduce Access to Precursor Ingredients
Scorecard Building
Potential Objective Details
Potential Measures and Data Sources
Potential Actions and Partners
Resources to Investigate
More RTI on Reduce Access to Precursor Ingredients
PAGE MANAGER: [insert name here]
SUBJECT MATTER EXPERT: [fill out table below]
Reviewer | Date | Comments |
Sources